Torthaí cuardaigh - Lisa Bodei
- 1 - 20 toradh as 56 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes de réir F. Edward Boas, Lisa Bodei, Constantinos T. Sofocleous
Foilsithe / Cruthaithe 2017Revisão -
2
Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics de réir Kambiz Rahbar, Lisa Bodei, Michael J. Morris
Foilsithe / Cruthaithe 2019Revisão -
3
Current Concepts in <sup>68</sup>Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies de réir Lisa Bodei, Valentina Ambrosini, Ken Herrmann, Irvin M. Modlin
Foilsithe / Cruthaithe 2017Revisão -
4
Somatostatin Receptor 2–Targeting Compounds de réir Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom, Lisa Bodei
Foilsithe / Cruthaithe 2017Revisão -
5
The Status of Neuroendocrine Tumor Imaging: From Darkness to Light? de réir Lisa Bodei, Anders Sundin, Mark Kidd, Vikas Prasad, Irvin M. Modlin
Foilsithe / Cruthaithe 2014Artigo -
6
Radiopharmaceutical therapy in cancer: clinical advances and challenges de réir George Sgouros, Lisa Bodei, Michael R. McDevitt, Jessie R. Nedrow
Foilsithe / Cruthaithe 2020Revisão -
7
Radiotheranostics in oncology: current challenges and emerging opportunities de réir Lisa Bodei, Ken Herrmann, Heiko Schöder, Andrew M. Scott, Jason S. Lewis
Foilsithe / Cruthaithe 2022Revisão -
8
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors de réir Irvin M. Modlin, Harry R. Aslanian, Lisa Bodei, Ignat Drozdov, Mark Kidd
Foilsithe / Cruthaithe 2014Artigo -
9
Neuroendocrine Tumor Biomarkers: Current Status and Perspectives de réir Irvin M. Modlin, Kjell Öberg, Andrew Taylor, Ignat Drozdov, Lisa Bodei, Mark Kidd
Foilsithe / Cruthaithe 2014Artigo -
10
-
11
-
12
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” de réir Boudewijn Brans, Lisa Bodei, Francesco Giammarile, O. Lindén, Markus Luster, Wim J.G. Oyen, Jan Tennvall
Foilsithe / Cruthaithe 2007Revisão -
13
Yttrium-labelled peptides for therapy of NET de réir Lisa Bodei, Marta Cremonesi, Chiara Maria Grana, Marco Chinol, Silvia M. Baio, Stefano Severi, Giovanni Paganelli
Foilsithe / Cruthaithe 2012Revisão -
14
Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors de réir Lisa Bodei, Marta Cremonesi, Mark Kidd, Chiara Maria Grana, Stefano Severi, Irvin M. Modlin, Giovanni Paganelli
Foilsithe / Cruthaithe 2014Revisão -
15
The NETest de réir Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung
Foilsithe / Cruthaithe 2018Revisão -
16
Targeted therapy in nuclear medicine—current status and future prospects de réir Wim J.G. Oyen, Lisa Bodei, Francesco Giammarile, Helmut R. Maëcke, Jan Tennvall, Markus Luster, Boudewijn Brans
Foilsithe / Cruthaithe 2007Revisão -
17
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors de réir Anna Malczewska, Beata Kos‐Kudła, Mark Kidd, Ignat Drozdov, Lisa Bodei, Somer Matar, Kjell Öberg, Irvin M. Modlin
Foilsithe / Cruthaithe 2019Revisão -
18
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy de réir Lisa Bodei, Heiko Schöder, Richard P. Baum, Ken Herrmann, Jonathan Strosberg, Martyn Caplin, Kjell Öberg, Irvin M. Modlin
Foilsithe / Cruthaithe 2020Revisão -
19
Neuroendocrine Neoplasms of the Small Bowel and Pancreas de réir Ashley Kieran Clift, Mark Kidd, Lisa Bodei, Christos Toumpanakis, Richard P. Baum, Kjell Öberg, Irvin M. Modlin, Andrea Frilling
Foilsithe / Cruthaithe 2019Revisão -
20
GEP–NETs UPDATE: Radionuclide therapy in neuroendocrine tumors de réir Wouter A. van der Zwan, Lisa Bodei, Jan Mueller‐Brand, Wouter W. de Herder, Larry K. Kvols, Dik J. Kwekkeboom
Foilsithe / Cruthaithe 2014Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Neuroendocrine tumors
Nuclear medicine
Oncology
Radionuclide therapy
Biology
Cancer
Medical physics
Pathology
Receptor
Somatostatin
Biochemistry
Biomarker
Chemistry
Gastroenterology
Peptide receptor
Radiation therapy
Radiology
Biotechnology
In vivo
Somatostatin receptor
Chromogranin A
Disease
Immunohistochemistry
Prostate cancer
Bioinformatics
Cancer research
Clinical trial
Dosimetry